Liquid biopsy system for capturing and analyzing circulating tumor cells from patient blood samples. Reported capture efficiency of 73% for comprehensive tumor cell analysis in oncology applications.
Manufactured by
Hangzhou Zhejiang, China
The company integrates scientific research, development, production and sales. It is an enterprise specializing in the production of endoscopes, surgical instruments and medical auxiliary equipment with various disciplines. At present, it has a base and a research and development center. The company has established a new product and new technology R D center with Zhejiang University. The center has been recognized as the high-tech enterprise R D center of Hangzhou by the Science and Technology Bureau of Hangzhou, and has been recognized as the enterprise technology of Hangzhou by the Economic Commission of Hangzhou. center. Time and Space TSCS is a trademark registered by the company in the State Administration for Industry and Commerce. Time and space products, time is the time, unlimited innovation reflects the pulse of the times; air waiting is the space, constantly absorbing the world's most cutting-edge technology and developing its own special products. The company's products include general surgery, thoracic surgery, gynecology, otolaryngology, endocrinology, orthopedics, cranial neurosurgery, etc. The products are highly favored by professors of many large hospitals and praised by the National Medical Device Monitoring Center. System operation: The company has fully implemented IS09001:2008, ISO13485:2003 quality management system. In 2008, it successfully passed the national medical device industry certification center demonstration and the European Community CE certification. In 2009, the company obtained the FDA registration number: Regisration Number: 3007675948. The company is willing to provide high-quality and reliable services for new and old customers, and act as a permanent rear security system.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Aliko Scientific SA
France · 3 relevant products
guangzhou biotron technolongy co.,ltd
China · 4 relevant products
NOROVA
China · 4 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 1 relevant product
Burning Rock Dx Co. Ltd.
China · 4 relevant products
DMB Diagnostics
Germany · 3 relevant products
Jiulu
China · 1 relevant product
U-GEN BIOTECHNOLOGY INC.
China · 1 relevant product
GENETRON HEALTH (BEIJING) CO., LTD
China · 1 relevant product
Biopsense Oy
Finland · 3 relevant products
16 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 45 closest product alternatives
Aliko Scientific SA · France
Liquid biopsy platform designed to detect and analyze circulating tumor cells in patient samples. Enables non-invasive cancer monitoring and personalized medicine applications through advanced genetic testing.
guangzhou biotron technolongy co.,ltd · China
A next-generation circulating tumor cell detection system based on microfluidic chips and AI interpretation that captures cancer cells from a single blood sample. It enables non-invasive tumor monitoring, assists in lung nodule diagnosis, perioperative guidance, and treatment monitoring for precision oncology.
NOROVA · China
An independently developed liquid biopsy platform for detecting circulating tumor cells with high sensitivity and specificity. This non-invasive blood-based test provides comprehensive tumor-related information for malignant tumor diagnosis and treatment guidance.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Circulating Tumor Cell (CTC) detection products that identify and analyze tumor cells in patient blood samples. These products provide critical diagnostic information for cancer monitoring and treatment planning.
Burning Rock Dx Co. Ltd. · China
Enumeration and characterization of viable tumor cells circulating in blood samples. Provides prognostic information and enables functional analysis of metastatic disease.
DMB Diagnostics · Germany
A research-use-only diagnostic test that isolates and analyzes circulating tumour cells from a single blood draw. Provides data on tumour biology and potential therapeutic response without requiring tissue biopsy.
Burning Rock Dx Co. Ltd. · China
Circulating tumor DNA detection and analysis system for cancer diagnosis and monitoring. Enables early cancer detection through blood-based liquid biopsy technology with high sensitivity and specificity.
DMB Diagnostics · Germany
An in-house sample processing service for research sites that analyzes circulating tumour cells from blood samples. Samples are submitted to the laboratory and research data is returned within approximately 5 working days, supporting research into cancer biology and personalized therapeutic approaches.
NOROVA · China
An independently developed platform for detecting circulating tumor DNA with high sensitivity and specificity compared to traditional detection methods. This liquid biopsy approach enables non-invasive, painless diagnosis through a single blood sample for comprehensive cancer patient support.
guangzhou biotron technolongy co.,ltd · China
Advanced liquid biopsy system for non-invasive detection and analysis of circulating tumor markers, circulating tumor cells, and cell-free DNA from blood samples.
NOROVA · China
A diagnostic service utilizing independently developed CTC (circulating tumor cells) and ctDNA (circulating tumor DNA) detection platforms with high sensitivity and specificity. Compared to traditional detection methods, it can identify more disease information to achieve individualized precision therapy for tumor patients. Liquid biopsy is minimally invasive and painless, providing comprehensive tumor-related information from a single blood sample, offering strong support for malignant tumor diagnosis and treatment as a complement to traditional tissue biopsy.
DMB Diagnostics · Germany
A research-use-only liquid biopsy assay designed to detect and quantify living circulating tumour cells (CTCs) in blood samples. The minimally invasive test uses a small 15 ml EDTA blood sample and is non-invasive and repeatable over time. Sentinel qCTC provides researchers with insights into tumour biology, disease dynamics, and potential biomarker applications. The assay is progressing towards CE mark registration as a medical device and is intended for research applications only, not yet cleared for clinical diagnostic use.
33 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products